4//SEC Filing
PROVECTUS BIOPHARMACEUTICALS, INC. 4
Accession 0001140361-14-027129
$PVCTCIK 0000315545operating
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 10:22 AM ET
Size
7.5 KB
Accession
0001140361-14-027129
Insider Transaction Report
Form 4
CULPEPPER PETER R
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2014-06-28$1.25/sh+100,000$125,000→ 1,112,332 total - Exercise/Conversion
Stock Option (right to buy)
2014-06-28−100,000→ 0 totalExercise: $1.25From: 2004-06-28Exp: 2014-06-28→ Common Stock (100,000 underlying)
Holdings
- 121,000(indirect: By 401(k))
Common Stock
Documents
Issuer
PROVECTUS BIOPHARMACEUTICALS, INC.
CIK 0000315545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000315545
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 10:22 AM ET
- Size
- 7.5 KB